USNA
USANA Health Sciences, Inc.
NYSEUSDEQUITY
Consumer Defensive
DELAYED
Sell
-24/100
Last price
14.83
▼ 0.02 (0.13%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
14.85
Day high
15.06
Day low
14.83
Volume
90.83K
Market cap
$274.01M
P/E (TTM)
—
52W range
12.57 – 26.76
Trailing performance
Returnvs SPY
1W
+0.88%
-1.1%
1M
-0.87%
-2.0%
3M
-29.95%
-34.5%
6M
-15.45%
-33.6%
YTD
-24.45%
-38.7%
1Y
-45.40%
-61.8%
3Y
-74.70%
-156.9%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on USNA open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-11.96K
Net selling
Buy transactions
16
20.59K shares
Sell transactions
8
32.55K shares
Net transactions
+24
Buys less sells
Sell : buy shares
1.6 : 1
Mixed
Insider-held shares
7.55M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jul 24, 26 | BENEDICT PETER Chief Technology Officer |
— | 598 | — | Direct |
| Jul 24, 26 | ARMSTRONG KATHRYN MICHELLE PH.D. Officer |
— | 1.17K | — | Direct |
| Jul 23, 26 | NIXON J SCOTT Director |
— | 1.63K | — | Direct |
| Jul 23, 26 | PELOSI PEGGIE J Director |
— | 1.63K | — | Direct |
| Jul 23, 26 | FLEMING JOHN TURMAN Director |
— | 1.63K | — | Direct |
| Jul 23, 26 | DING XIA Director |
— | 1.63K | — | Direct |
| Jul 23, 26 | FULLER GILBERT A Director |
— | 1.63K | — | Direct |
| Jul 23, 26 | WINSSINGER FREDERIC J. Director |
— | 1.63K | — | Direct |
| Jul 23, 26 | WOOD TIMOTHY E Director |
— | 1.63K | — | Direct |
| Jun 16, 26 | NEIDIG BRENT LOWELL Officer |
SELL | 5.00K | $97.30K | Direct |
| Jun 15, 26 | NEIDIG BRENT LOWELL Officer |
SELL | 2.51K | $50.47K | Direct |
| Jun 8, 26 | JONES PAUL A Officer |
SELL | 5.56K | $102.88K | Direct |
| Jun 1, 26 | FLEMING JOHN TURMAN Director |
SELL | 2.45K | $43.93K | Direct |
| May 28, 26 | JONES PAUL A Officer |
SELL | 6.81K | $129.11K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BROWN JIM H |
Chief Executive Officer | 16.93K | Conversion of Exercise of derivative security |
DING XIA |
Director | 8.28K | Conversion of Exercise of derivative security |
GUEST KEVIN G |
Chief Executive Officer | 45.38K | Conversion of Exercise of derivative security |
MULHAM DAVID MULHAM |
Officer | 8.39K | Sale |
NIXON J SCOTT |
Director | 11.45K | Conversion of Exercise of derivative security |
NOOT WALTER |
Chief Operating Officer | 9.26K | Conversion of Exercise of derivative security |
PELOSI PEGGIE J |
Director | 6.06K | Conversion of Exercise of derivative security |
WENTZ MYRON W |
Beneficial Owner of more than 10% of a Class of Security | — | Stock Gift |
WINSSINGER FREDERIC J. |
Director | 9.73K | Conversion of Exercise of derivative security |
WOOD TIMOTHY E |
Director | 11.84K | Conversion of Exercise of derivative security |
Fundamentals
Market cap$274.01M
Enterprise value$150.11M
Revenue (TTM)$913.36M
Gross profit$707.36M
EBITDA$73.92M
Net income$-22.16M
EPS (TTM)$-1.20
Free cash flow$49.13M
Total cash$168.56M
Total debt$0
Book value / share$28.51
Shares outstanding18.48M
Float9.93M
Short % of float6.90%
Dividend yield0.00%
Beta (5Y)0.68
Valuation & profitability ratios
Trailing P/E—
Forward P/E8.38
PEG ratio0.70
Price / sales—
Price / book0.52
EV / revenue0.16
EV / EBITDA2.03
Gross margin77.45%
Operating margin4.09%
Profit margin-2.43%
Return on equity-5.06%
Return on assets3.61%
Debt / equity—
Current ratio2.66
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $925.26M | $854.50M | $921.01M | $998.60M | +8.3% |
| Operating revenue | $925.26M | $854.50M | $921.01M | $998.60M | +8.3% |
| Cost of revenue | $200.85M | $161.21M | $176.69M | $193.89M | +24.6% |
| Gross profit | $724.40M | $693.29M | $744.32M | $804.71M | +4.5% |
| Selling, general & admin | $337.37M | $263.27M | $256.99M | $262.30M | +28.1% |
| Total operating expense | $673.54M | $626.97M | $651.25M | $697.10M | +7.4% |
| Operating income | $50.86M | $66.32M | $93.07M | $107.61M | -23.3% |
| Net interest income | $1.57M | $11.04M | $9.38M | $3.60M | -85.7% |
| Pre-tax income | $41.53M | $76.35M | $102.45M | $108.62M | -45.6% |
| Tax provision | $30.05M | $34.29M | $38.66M | $39.27M | -12.4% |
| Net income | $10.76M | $42.03M | $63.79M | $69.35M | -74.4% |
| Net income to common | $10.76M | $42.03M | $63.79M | $69.35M | -74.4% |
| Basic EPS | 0.59 | 2.21 | 3.33 | 3.61 | -73.3% |
| Diluted EPS | 0.58 | 2.19 | 3.30 | 3.59 | -73.5% |
| EBIT | $42.37M | $76.63M | $102.72M | $108.81M | -44.7% |
| EBITDA | $82.07M | $98.86M | $123.11M | $130.22M | -17.0% |
| Basic shares | 18.28M | 19.06M | 19.13M | 19.21M | -4.1% |
| Diluted shares | 18.57M | 19.16M | 19.34M | 19.31M | -3.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $158.38M | $181.77M | $330.42M | $288.42M | -12.9% |
| Cash & short-term investments | $158.38M | $181.77M | $330.42M | $288.42M | -12.9% |
| Inventory | $102.61M | $69.73M | $61.45M | $67.09M | +47.1% |
| Total current assets | $288.40M | $279.19M | $417.75M | $384.38M | +3.3% |
| Property, plant & equipment | $94.38M | $94.56M | $99.81M | $97.77M | -0.2% |
| Goodwill & intangibles | $271.11M | $295.99M | $47.02M | $49.80M | -8.4% |
| Total assets | $742.91M | $748.19M | $632.76M | $596.55M | -0.7% |
| Total current liabilities | $128.56M | $139.63M | $118.84M | $143.83M | -7.9% |
| Current debt | $14.00M | $23.00M | $786.00K | — | -39.1% |
| Total debt | $19.65M | $29.01M | $8.06M | $6.89M | -32.3% |
| Total liabilities | $156.64M | $161.86M | $135.56M | $162.08M | -3.2% |
| Retained earnings | $465.72M | $478.94M | $445.22M | $391.64M | -2.8% |
| Shareholder equity | $533.10M | $532.11M | $497.20M | $434.47M | +0.2% |
| Working capital | $159.84M | $139.56M | $298.90M | $240.55M | +14.5% |
| Net tangible assets | $261.99M | $236.12M | $450.18M | $384.67M | +11.0% |
| Shares issued | 18.28M | 19.06M | 19.13M | 19.21M | -4.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $11.48M | $42.06M | $63.79M | $69.35M | -72.7% |
| Depreciation & amortisation | $39.70M | $22.23M | $20.39M | $21.41M | +78.6% |
| Stock-based compensation | $13.83M | $14.56M | $14.60M | $13.33M | -5.0% |
| Change in working capital | -$43.08M | -$13.00M | -$28.00M | $771.00K | -231.3% |
| Operating cash flow | $22.35M | $60.99M | $70.64M | $103.90M | -63.4% |
| Capital expenditure | -$13.82M | -$10.07M | -$14.49M | -$10.40M | -37.2% |
| Investing cash flow | -$10.13M | -$213.09M | -$11.97M | -$12.37M | +95.2% |
| Share buybacks | -$27.51M | -$9.44M | -$11.60M | -$25.38M | -191.3% |
| Financing cash flow | -$40.60M | $9.55M | -$14.24M | -$30.09M | -525.0% |
| Free cash flow | $8.53M | $50.92M | $56.15M | $93.50M | -83.3% |
| End cash position | $161.24M | $184.51M | $333.25M | $291.32M | -12.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $223.27M | $250.22M | $226.20M | $213.67M | $235.85M | -10.8% |
| Operating revenue | $223.27M | $250.22M | $226.20M | $213.67M | $235.85M | -10.8% |
| Cost of revenue | $48.34M | $59.44M | $49.41M | $48.81M | $50.18M | -18.7% |
| Gross profit | $174.93M | $190.78M | $176.79M | $164.85M | $185.66M | -8.3% |
| Selling, general & admin | $82.32M | $88.25M | $78.08M | $85.95M | $81.91M | -6.7% |
| Total operating expense | $165.79M | $176.91M | $159.54M | $163.63M | $168.95M | -6.3% |
| Operating income | $9.14M | $13.87M | $17.25M | $1.22M | $16.72M | -34.1% |
| Net interest income | $595.00K | $197.00K | $372.00K | $529.00K | $360.00K | +202.0% |
| Pre-tax income | -$18.90M | $15.46M | $4.18M | $1.79M | $18.82M | -222.2% |
| Tax provision | $9.05M | $8.51M | $5.77M | $8.46M | $8.37M | +6.4% |
| Net income | -$21.38M | $6.96M | -$1.77M | -$6.52M | $9.65M | -407.3% |
| Net income to common | -$21.38M | $6.96M | -$1.77M | -$6.52M | $9.65M | -407.3% |
| Basic EPS | -1.16 | 0.41 | -0.10 | -0.36 | 0.52 | -382.9% |
| Diluted EPS | -1.16 | 0.41 | -0.10 | -0.36 | 0.52 | -382.9% |
| EBIT | -$18.90M | $15.71M | $4.30M | $1.84M | $19.08M | -220.3% |
| EBITDA | -$9.73M | $25.49M | $14.59M | $11.41M | $28.68M | -138.2% |
| Basic shares | 18.49M | 18.40M | 18.28M | 18.29M | 18.51M | +0.5% |
| Diluted shares | 18.49M | 18.41M | 18.30M | 18.29M | 18.54M | +0.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $168.56M | $162.75M | $158.38M | $145.35M | $151.34M | — | +3.6% |
| Cash & short-term investments | $168.56M | $162.75M | $158.38M | $145.35M | $151.34M | — | +3.6% |
| Accounts receivable | $3.34M | $9.66M | — | — | — | — | -65.4% |
| Inventory | $86.34M | $96.36M | $102.61M | $90.78M | $83.27M | — | -10.4% |
| Total current assets | $281.07M | $294.23M | $288.40M | $264.06M | $261.87M | — | -4.5% |
| Property, plant & equipment | $94.27M | $94.63M | $94.38M | $96.21M | $96.53M | — | -0.4% |
| Goodwill & intangibles | $233.76M | $267.03M | $271.11M | $282.45M | $286.98M | — | -12.5% |
| Total assets | $703.21M | $738.97M | $742.91M | $726.59M | $734.53M | — | -4.8% |
| Total current liabilities | $105.67M | $117.24M | $128.56M | $118.66M | $121.63M | — | -9.9% |
| Current debt | — | $14.00M | $14.00M | — | — | $23.00M | — |
| Total debt | — | $14.00M | $19.65M | — | — | $23.00M | — |
| Total liabilities | $132.24M | $144.18M | $156.64M | $145.04M | $148.97M | — | -8.3% |
| Retained earnings | $451.85M | $473.24M | $465.72M | $467.50M | $474.02M | — | -4.5% |
| Shareholder equity | $526.31M | $543.55M | $533.10M | $528.07M | $531.06M | — | -3.2% |
| Working capital | $175.39M | $176.99M | $159.84M | $145.40M | $140.24M | — | -0.9% |
| Net tangible assets | $292.55M | $276.52M | $261.99M | $245.63M | $244.08M | — | +5.8% |
| Shares issued | 18.46M | 18.46M | 18.28M | 18.27M | 18.26M | — | +0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$27.95M | $6.96M | -$1.59M | -$6.66M | $10.44M | -501.7% |
| Depreciation & amortisation | $9.17M | $9.79M | $10.29M | $9.57M | $9.60M | -6.3% |
| Stock-based compensation | $3.40M | $3.45M | $3.75M | $3.58M | $3.62M | -1.4% |
| Change in working capital | $13.11M | -$13.86M | -$18.17M | -$10.93M | -$4.47M | +194.6% |
| Operating cash flow | $23.32M | $9.76M | -$3.39M | -$1.96M | $12.22M | +138.9% |
| Capital expenditure | -$3.15M | -$2.65M | -$2.79M | -$3.20M | -$5.03M | -19.3% |
| Investing cash flow | -$4.06M | -$2.60M | $1.11M | -$3.20M | -$4.16M | -56.2% |
| Share buybacks | $0 | $0 | $0 | $0 | -$15.21M | — |
| Financing cash flow | -$14.03M | -$3.64M | $13.45M | -$979.00K | -$38.61M | -285.2% |
| Free cash flow | $20.16M | $7.11M | -$6.18M | -$5.16M | $7.19M | +183.4% |
| End cash position | $171.51M | $165.66M | $161.24M | $148.15M | $154.13M | +3.5% |
Options analytics
Put / call volume
0.28
Call-heavy session
Put / call open interest
0.44
Positioning, not flow
Max pain
15.00
+1.1% from spot
ATM implied vol
3.1%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
39
Contracts, this expiry
Put volume
11
Contracts, this expiry
Heaviest call OI
17.50
93 contracts
Heaviest put OI
15.00
31 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.43 | -0.07 | -116.3% |
| Mar 2026 | 0.44 | 0.61 | +38.6% |
| Dec 2025 | 0.41 | 0.60 | +46.3% |
| Sep 2025 | -0.15 | -0.15 | 0.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.11 | 1 | $219.02M | +2.5% |
| Next quarter | 0.11 | 1 | $217.06M | -4.0% |
| Current year | 0.76 | 1 | $909.57M | -1.7% |
| Next year | 1.77 | 1 | $949.84M | +4.4% |
Analyst targets & ownership
Mean target$25.00
High target$25.00
Low target$25.00
Implied upside68.58%
Analyst count1
ConsensusNONE
Strong buy / Buy0 / 0
Hold0
Sell / Strong sell0 / 0
Held by insiders40.88%
Held by institutions62.96%
Institutions holding203
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
14.57
+1.81% from price
SMA 20
14.66
+1.14% from price
SMA 50
15.31
-3.15% from price
SMA 100
17.64
-15.93% from price
SMA 200
18.57
-20.15% from price
EMA 12
14.65
+1.25% from price
EMA 26
14.79
+0.27% from price
EMA 50
15.57
-4.77% from price
RSI (14)
50.2
Neutral
MACD (12,26,9)
-0.14
Hist 0.12
ATR (14)
0.49
3.28% of price
Realised vol 30D
33.7%
Annualised
Bollinger upper
15.30
20, 2σ
Bollinger lower
14.03
20, 2σ
50 / 200 cross
Death
15.31 vs 18.57
Trend bias
Below 200
-20.15%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.20
More volatile than market
Correlation to SPY
0.27
Largely independent
Realised vol 30D
33.7%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-51.6%
Peak to trough
Max drawdown 5Y
-87.6%
Peak to trough
ATR 14
0.49
3.28% of price
Beta (reported)
0.68
5Y monthly, from filing
Short interest
Shares short
754.69K
Prior 756.03K
Change vs prior
-0.2%
Shorts covering
% of float
6.90%
Normal
% of shares out
4.08%
Against total outstanding
Days to cover
3.5
Liquid
Float
9.93M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 27, 25 | DA Davidson | MAINTAINED | Neutral | Neutral |
| Jan 2, 25 | DA Davidson | MAINTAINED | Neutral | Neutral |
| Oct 23, 24 | DA Davidson | MAINTAINED | Neutral | Neutral |
| Jul 25, 24 | DA Davidson | MAINTAINED | Neutral | Neutral |
| May 7, 24 | DA Davidson | MAINTAINED | Neutral | Neutral |
| Feb 22, 24 | DA Davidson | MAINTAINED | Neutral | Neutral |
| Oct 25, 23 | DA Davidson | MAINTAINED | Neutral | Neutral |
| Apr 26, 23 | DA Davidson | MAINTAINED | — | Neutral |
| Feb 13, 23 | DA Davidson | MAINTAINED | — | Neutral |
| Oct 27, 22 | DA Davidson | MAINTAINED | — | Neutral |
| Jul 28, 22 | DA Davidson | MAINTAINED | — | Neutral |
| Jul 12, 22 | DA Davidson | MAINTAINED | — | Neutral |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split2:1
Split dateNov 23, 2016
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-10-05
Periodic Financial Reports
10-Q · 2026-08-13
Corporate Changes & Voting Matters
8-K · 2026-08-04
Annual report of employee stock purchase
11-K · 2026-06-15
Corporate Changes & Voting Matters
8-K · 2026-05-20
Periodic Financial Reports
10-Q · 2026-05-12
Corporate Changes & Voting Matters
8-K · 2026-05-05
Annual Report to Shareholders
ARS · 2026-04-07
Headlines
USANA Health Sciences and University of Utah Athletics Announce New Partnership
PR Newswire · 2h ago
USANA CEO Kevin Guest Shares Three Ways to Celebrate International Music Day
CNW Group · 6d ago
USANA CEO Kevin Guest Shares Three Ways to Celebrate International Music Day
PR Newswire · 6d ago
3 Value Stocks We Steer Clear Of
StockStory · 7d ago
3 Cash-Producing Stocks with Warning Signs
StockStory · 16d ago
Implied Volatility Surging for USANA Health Stock Options
Zacks · 23d ago
1 Stock Under $50 to Target This Week and 2 We Brush Off
StockStory · 26d ago
Protein Pop Launches Protein Pop Balance, a Clear Prebiotic Soda with 15 Grams of Protein and 5 Grams of Fiber
PR Newswire · 34d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.